Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04052971
Recruitment Status : Recruiting
First Posted : August 12, 2019
Last Update Posted : January 30, 2020
Novotech (Australia) Pty Limited
Information provided by (Responsible Party):
Abion Inc

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : December 31, 2023